GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+29.98%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$234M
AUM Growth
+$234M
Cap. Flow
-$45M
Cap. Flow %
-19.2%
Top 10 Hldgs %
57.93%
Holding
46
New
9
Increased
6
Reduced
20
Closed
9

Top Buys

1
QQQ icon
Invesco QQQ Trust
QQQ
$13.3M
2
SGEN
Seagen Inc. Common Stock
SGEN
$10.9M
3
IOVA icon
Iovance Biotherapeutics
IOVA
$8.31M
4
AKRO icon
Akero Therapeutics
AKRO
$4.66M
5
ASND icon
Ascendis Pharma
ASND
$4.27M

Top Sells

1
RLMD icon
Relmada Therapeutics
RLMD
$15.7M
2
VRDN icon
Viridian Therapeutics
VRDN
$10.8M
3
PCVX icon
Vaxcyte
PCVX
$9.59M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$8.55M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
$7.39M

Sector Composition

1 Healthcare 94.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RAPT icon
26
RAPT Therapeutics
RAPT
$187M
$2.48M 1.06%
125,000
+35,000
+39% +$693K
KZR icon
27
Kezar Life Sciences
KZR
$28.5M
$2.39M 1.02%
339,907
-185,093
-35% -$1.3M
RNA icon
28
Avidity Biosciences
RNA
$6.12B
$2.22M 0.95%
+100,000
New +$2.22M
TARS icon
29
Tarsus Pharmaceuticals
TARS
$2.44B
$1.17M 0.5%
80,000
-40,000
-33% -$587K
WHWK
30
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$1.16M 0.49%
90,000
-110,000
-55% -$1.41M
RXDX
31
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$1.09M 0.46%
+9,896
New +$1.09M
XFOR icon
32
X4 Pharmaceuticals
XFOR
$70M
$993K 0.42%
+1,000,000
New +$993K
BPMC
33
DELISTED
Blueprint Medicines
BPMC
$876K 0.37%
20,000
-45,000
-69% -$1.97M
DSGN icon
34
Design Therapeutics
DSGN
$339M
$850K 0.36%
82,853
-17,147
-17% -$176K
SYRE icon
35
Spyre Therapeutics
SYRE
$1.02B
$360K 0.15%
800,000
-200,000
-20% -$90K
ALT icon
36
Altimmune
ALT
$325M
– –
-435,000
Closed -$5.56M
BIIB icon
37
Biogen
BIIB
$20.8B
– –
-3,750
Closed -$1M
FOLD icon
38
Amicus Therapeutics
FOLD
$2.42B
– –
-500,000
Closed -$5.22M
MLTX icon
39
MoonLake Immunotherapeutics
MLTX
$3.78B
– –
-300,000
Closed -$2.33M
RLMD icon
40
Relmada Therapeutics
RLMD
$48.8M
– –
-425,000
Closed -$15.7M
RYTM icon
41
Rhythm Pharmaceuticals
RYTM
$6.75B
– –
-65,000
Closed -$1.59M
XBI icon
42
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
ITCI
43
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-60,000
Closed -$2.79M
DICE
44
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
0
– –
TCDA
45
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-200,000
Closed -$2.1M
HZNP
46
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-75,000
Closed -$4.64M
1
2